Q3 2025 Forian Inc Earnings Call Transcript
Key Points
- Forian Inc (FORA) reported a 66% year-over-year increase in revenue for the third quarter, reaching $7.76 million, driven by the Kyber Data Science acquisition and expansion in health economics and outcomes research projects.
- The integration of Kyber has strengthened Forian's analytical capabilities and expanded its reach into the financial markets segment, providing high-quality healthcare data for predictive insights.
- Forian's data factory is a critical differentiator, integrating and enriching data from various sources to create a unified view of the healthcare ecosystem, enhancing client decision-making.
- The company demonstrated improved operating leverage with a reduced net loss of $151,000 and an increased adjusted EBITDA of $471,000 compared to the prior year period.
- Forian expects full-year 2025 revenue to finish near the high end of its previously communicated range, indicating strong growth prospects and ongoing client engagement.
- Forian Inc (FORA) reported a net loss of $151,000 for the third quarter, indicating that the company is still not profitable.
- Operating loss for the quarter was approximately $0.5 million, although reduced from the previous year, it still reflects ongoing financial challenges.
- Net other income decreased by $0.2 million due to lower interest income and expense, impacting overall financial performance.
- The company incurred higher expenses related to the inclusion of Kyber operations and increased data costs, affecting profitability.
- Forian's adjusted EBITDA outlook for 2025 ranges from negative $1 million to positive $1 million, indicating uncertainty in achieving consistent profitability.
Greetings and welcome to Forian Inc. third quarter 2025 financial results conference call and webcast. (Operator Instructions) Participating today from Forian are Max Wygod, Executive Chairman and Chief Executive Officer; and Michael Vesey, Chief Financial Officer.
Before we begin, I would like to remind you that management's remarks today may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements due to a variety of important factors, including those discussed in the risk factors section of the company's annual report on Form 10-K, filed with the SEC on April 11, 2025.
In particular, management will discuss an estimate of its full-year 2025 revenue outlook as of today. Estimating financial performance accurately for future performance is difficult as it involves assumptions and internal estimates that may prove to be incorrect and is based on plans and circumstances that may change. There is therefore a significant risk that actual results
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

